BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mashel TV, Tarakanchikova YV, Muslimov AR, Zyuzin MV, Timin AS, Lepik KV, Fehse B. Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods. Biomaterials 2020;258:120282. [DOI: 10.1016/j.biomaterials.2020.120282] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Pérez-carrión MD, Posadas I. Dendrimers in Neurodegenerative Diseases. Processes 2023;11:319. [DOI: 10.3390/pr11020319] [Reference Citation Analysis]
2 Martinez MG, Smekalova E, Combe E, Gregoire F, Zoulim F, Testoni B. Gene Editing Technologies to Target HBV cccDNA. Viruses 2022;14. [PMID: 36560658 DOI: 10.3390/v14122654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Cheng D, Wang Y, Li Z, Xiong H, Sun W, Xi S, Zhou S, Liu Y, Ni C. Liposomal UHRF1 siRNA shows lung fibrosis treatment potential through regulation of fibroblast activation. JCI Insight 2022;7:e162831. [PMID: 36166308 DOI: 10.1172/jci.insight.162831] [Reference Citation Analysis]
4 Viegas JSR, Bentley MVLB, Vicentini FTMDC. Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103964] [Reference Citation Analysis]
5 Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01610-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Li Y, Pan Y, Chen C, Li Z, Du S, Luan X, Gao Y, Han X, Song Y. Multistage-Responsive Gene Editing to Sensitize Ion-Interference Enhanced Carbon Monoxide Gas Therapy. Small 2022;:e2204244. [PMID: 36055775 DOI: 10.1002/smll.202204244] [Reference Citation Analysis]
7 Scully MA, Sterin EH, Day ES. Membrane-wrapped nanoparticles for nucleic acid delivery. Biomater Sci 2022. [PMID: 35796319 DOI: 10.1039/d2bm00447j] [Reference Citation Analysis]
8 Nie W, Chen J, Wang B, Gao X. Nonviral vector system for cancer immunogene therapy. MedComm – Biomaterials and Applications 2022;1:mba2.10. [DOI: 10.1002/mba2.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jiang Z, Fu M, Zhu D, Wang X, Li N, Ren L, He J, Yang G. Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering. Cytokine Growth Factor Rev 2022:S1359-6101(22)00039-9. [PMID: 35690567 DOI: 10.1016/j.cytogfr.2022.05.003] [Reference Citation Analysis]
10 Ishikawa R, Yoshida S, Sawada SI, Sasaki Y, Akiyoshi K. Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos. Cancers (Basel) 2022;14:2635. [PMID: 35681615 DOI: 10.3390/cancers14112635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ding Y, Wang H, Wang Y, Li L, Ding J, Yuan C, Xu T, Xu H, Xie H, Zhu N, Hu X, Fang H, Tan S. Co-delivery of luteolin and TGF-β1 plasmids with ROS-responsive virus-inspired nanoparticles for microenvironment regulation and chemo-gene therapy of intervertebral disc degeneration. Nano Res . [DOI: 10.1007/s12274-022-4285-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang S, Lei B, Zhang E, Gong P, Gu J, He L, Han L, Yuan Z. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. IJN 2022;Volume 17:1757-81. [DOI: 10.2147/ijn.s355366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Florio F, Accordini S, Libergoli M, Biressi S. Targeting Muscle-Resident Single Cells Through in vivo Electro-Enhanced Plasmid Transfer in Healthy and Compromised Skeletal Muscle. Front Physiol 2022;13:834705. [DOI: 10.3389/fphys.2022.834705] [Reference Citation Analysis]
14 Puhl DL, Mohanraj D, Nelson DW, Gilbert RJ. Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools. Adv Drug Deliv Rev 2022;183:114161. [PMID: 35183657 DOI: 10.1016/j.addr.2022.114161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Feng S, Wang Z, Li A, Xie X, Liu J, Li S, Li Y, Wang B, Hu L, Yang L, Guo T. Strategies for High-Efficiency Mutation Using the CRISPR/Cas System. Front Cell Dev Biol 2021;9:803252. [PMID: 35198566 DOI: 10.3389/fcell.2021.803252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mukai H, Ogawa K, Kato N, Kawakami S. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics. Drug Metabolism and Pharmacokinetics 2022. [DOI: 10.1016/j.dmpk.2022.100450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
17 Xiang S, Hammer B, Kremer K, Müllen K, Weil T. Engineering surface amphiphilicity of polymer nanostructures. Progress in Polymer Science 2022;124:101489. [DOI: 10.1016/j.progpolymsci.2021.101489] [Reference Citation Analysis]
18 Liao Z, Huo S, Liang X. Preparation of Ultrasmall Gold Nanoparticles for Nuclear-Based Gene Delivery. Biomaterial Engineering 2022. [DOI: 10.1007/978-981-16-5419-0_17] [Reference Citation Analysis]
19 Riecken K, Głów D, Fehse B. How to package and SEND mRNA: a novel "humanized" vector system based on endogenous retroviruses. Signal Transduct Target Ther 2021;6:384. [PMID: 34741008 DOI: 10.1038/s41392-021-00803-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Chen P, He X, Tian XL, Zhang J, Yu XQ. One-step fabrication of functional carbon dots with long wavelength emission for gene delivery and bio-imaging. J Mater Chem B 2021;9:8518-29. [PMID: 34568886 DOI: 10.1039/d1tb01622a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Büning H, Fehse B, Ivics Z, Kochanek S, Koehl U, Kupatt C, Mussolino C, Nettelbeck DM, Schambach A, Uckert W, Wagner E, Cathomen T. Gene Therapy "Made in Germany": A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy. Hum Gene Ther 2021;32:987-96. [PMID: 34662229 DOI: 10.1089/hum.2021.29178.hbu] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Lv W, Li T, Wang S, Wang H, Li X, Zhang S, Wang L, Xu Y, Wei W. The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer. Technol Cancer Res Treat 2021;20:15330338211045206. [PMID: 34605326 DOI: 10.1177/15330338211045206] [Reference Citation Analysis]
23 Zhang H, Qin C, An C, Zheng X, Wen S, Chen W, Liu X, Lv Z, Yang P, Xu W, Gao W, Wu Y. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Mol Cancer 2021;20:126. [PMID: 34598686 DOI: 10.1186/s12943-021-01431-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
24 des Rieux A. Stem cells and their extracellular vesicles as natural and bioinspired carriers for the treatment of neurological disorders. Current Opinion in Colloid & Interface Science 2021;54:101460. [DOI: 10.1016/j.cocis.2021.101460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang Y, Wang L, Wang J, Xin S, Sheng X. Enzyme-responsive polysaccharide supramolecular nanoassembly for enhanced DNA encapsulation and controlled release. Chinese Chemical Letters 2021;32:1902-6. [DOI: 10.1016/j.cclet.2021.01.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
26 Jiang Z, Li N, Zhu D, Ren L, Shao Q, Yu K, Yang G. Genetically modified cell sheets in regenerative medicine and tissue engineering. Biomaterials 2021;275:120908. [PMID: 34119885 DOI: 10.1016/j.biomaterials.2021.120908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
27 Collon K, Gallo MC, Lieberman JR. Musculoskeletal tissue engineering: Regional gene therapy for bone repair. Biomaterials 2021;275:120901. [PMID: 34091300 DOI: 10.1016/j.biomaterials.2021.120901] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
28 Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, Liang Y, Xia J. Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale 2021;13:1387-97. [PMID: 33350419 DOI: 10.1039/d0nr07622h] [Cited by in Crossref: 42] [Cited by in F6Publishing: 56] [Article Influence: 21.0] [Reference Citation Analysis]
29 Raik SV, Mashel TV, Muslimov AR, Epifanovskaya OS, Trofimov MA, Poshina DN, Lepik KV, Skorik YA. N-[4-(N,N,N-Trimethylammonium)Benzyl]Chitosan Chloride as a Gene Carrier: The Influence of Polyplex Composition and Cell Type. Materials (Basel) 2021;14:2467. [PMID: 34068680 DOI: 10.3390/ma14092467] [Reference Citation Analysis]
30 Hadjiargyrou M. What Do COVID-19 Vaccines Tell Us About Nucleic Acid Delivery In Vivo? Nucleic Acid Ther 2021. [PMID: 33960839 DOI: 10.1089/nat.2021.0013] [Reference Citation Analysis]
31 Tarakanchikova YV, Linnik DS, Mashel T, Muslimov AR, Pavlov S, Lepik KV, Zyuzin MV, Sukhorukov GB, Timin AS. Boosting transfection efficiency: A systematic study using layer-by-layer based gene delivery platform. Mater Sci Eng C Mater Biol Appl 2021;126:112161. [PMID: 34082966 DOI: 10.1016/j.msec.2021.112161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel) 2021;9:359. [PMID: 33918072 DOI: 10.3390/vaccines9040359] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 48.5] [Reference Citation Analysis]
33 Guo M, Meng Y, Qin X, Zhou W. Dopamine-Grafted Hyaluronic Acid Coated Hyperbranched Poly(β-Amino Esters)/DNA Nano-Complexes for Enhanced Gene Delivery and Biosafety. Crystals 2021;11:347. [DOI: 10.3390/cryst11040347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kuang J, Lyu Q, Wang J, Cui Y, Zhao J. Advances in base editing with an emphasis on an AAV-based strategy. Methods 2021:S1046-2023(21)00089-X. [PMID: 33774157 DOI: 10.1016/j.ymeth.2021.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Linnik DS, Tarakanchikova YV, Zyuzin MV, Lepik KV, Aerts JL, Sukhorukov G, Timin AS. Layer-by-Layer technique as a versatile tool for gene delivery applications. Expert Opinion on Drug Delivery 2021;18:1047-66. [DOI: 10.1080/17425247.2021.1879790] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
36 Uzieliene I, Kalvaityte U, Bernotiene E, Mobasheri A. Non-viral Gene Therapy for Osteoarthritis. Front Bioeng Biotechnol 2020;8:618399. [PMID: 33520968 DOI: 10.3389/fbioe.2020.618399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
37 Ansari I, Chaturvedi A, Chitkara D, Singh S. CRISPR/Cas mediated epigenome editing for cancer therapy. Semin Cancer Biol 2021:S1044-579X(20)30278-9. [PMID: 33421620 DOI: 10.1016/j.semcancer.2020.12.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Liao Z, Huo S, Liang X. Preparation of Ultrasmall Gold Nanoparticles for Nuclear-Based Gene Delivery. Biomaterial Engineering 2021. [DOI: 10.1007/978-981-33-6198-0_17-1] [Reference Citation Analysis]
39 Pan T, Zhou Q, Miao K, Zhang L, Wu G, Yu J, Xu Y, Xiong W, Li Y, Wang Y. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis. Theranostics 2021;11:1192-206. [PMID: 33391530 DOI: 10.7150/thno.48152] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
40 Xue VW, Wong SCC, Cho WCS. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment. Expert Opin Ther Targets 2020;24:1147-58. [PMID: 32893711 DOI: 10.1080/14728222.2020.1820986] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]